Evidence map›Paper›PMID 25729588›Full record

ReviewCurrent health sciences journal

Psychosocial issues in patients with chronic hepatitis B and C.

Aurelia Enescu, P Mitrut, Maria Balasoiu, Adriana Turculeanu, Anca Stefania Enescu

Abstract readReview
In one paragraph

Review in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Social Determinants of Stigma and Discrimination in Vietnamese Patients with Chronic Hepatitis B.International journal of environmental research and public health · 2019
    Article
  10. Socioeconomic Vulnerability to Depressive Symptoms in Patients with Chronic Hepatitis B.International journal of environmental research and public health · 2019
    Article
  11. Article
  12. Quality of Life of Chronic Hepatitis C Patients and Its Associated Factors.Osong public health and research perspectives · 2017
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aurelia EnescuEmergency Medicine Discipline, University of Medicine and Pharmacy of Craiova, Romania.
P MitrutMedical Semiology Discipline, University of Medicine and Pharmacy of Craiova, Romania.
Maria BalasoiuMicrobiology Discipline, University of Medicine and Pharmacy of Craiova, Romania.
Adriana TurculeanuMicrobiology Discipline, University of Medicine and Pharmacy of Craiova, Romania.
Anca Stefania Enescuresident doctor ENT, Clinical Hospital of Emergency Craiova.
University of Medicine and Pharmacy of Craiova · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psychosocial issues and the quality of life are important components at the patients diagnosed with chronic hepatitis B and C. In function of the severity of the infection with virus B or the patients who already have cirrhosis, the treatment and psychosocial education should be improved because they have bigger problems. The frequency of psychosocial disorders seems to be raised at the patients diagnosed with chronic hepatitis B. Factors as alcohol abuse and a low social support have a negatively impact above mental health of these patients. The prevalence rate of chronic hepatitis C infection at patients with severe mental illness can be nine times higher than in healthy population. Usually patients with chronic hepatitis B have a quality of life and a mental health better than patients with chronic hepatitis C. Patients with psychiatric affections (especially institutionalized people) have generally a higher risk of being infected with virus B in comparison with general population. Patients with chronic hepatitis B and C suggest a higher grade of stigmatization from society. Despite clinical challenges which treatment with interferon at patients with chronic hepatitis and comorbidities represents, recent studies indicate the fact that treatment can be administrated in safe conditions at patients with viral chronic hepatitis and psychiatric disorders.

Indexed as

: chronic hepatitis B and Cdepressionquality of lifestigma

Identifiers

PMID25729588
PMCPMC4340448
OpenAlexW2131249896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.